Results 101 to 110 of about 4,526 (167)

Microbiologic Findings in a Cohort of Patients with Erythema Migrans. [PDF]

Microorganisms
Ružić-Sabljić E, Maraspin V, Bogovič P, Rojko T, Ogrinc K, Jaklič M, Strle F.   +6 more
europepmc   +1 more source

Lyme disease with erythema migrans presenting concurrently with optic nerve perineuritis and abducens nerve palsy. [PDF]

BMJ Case Rep, 2020
Lundin MS, Sandel SL, Suciu CM, Spicehandler DA.   +3 more
europepmc   +1 more source

Is Doxycycline Appropriate for Routine Treatment of Young Children With Erythema Migrans? [PDF]

Pediatr Infect Dis J, 2019
Wormser GP, Strle F, Shapiro ED.
europepmc   +1 more source

Liječenje erythema migrans

Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 1999
U preglednom članku analizirana su dosadašnja klinička ispitivanja liječenja erythema migrans, lokaliziranog oblika lajmske borelioze. Unatoč tomu što je liječenje ove manifestacije bolesti za sada njabolje ispitano, mnoga pitanja ostaju neriješena.
openaire   +1 more source

A Rare Case of Pseudoglucagonoma Syndrome Masquerading as Necrolytic Migratory Erythema

JK Science
Necrolytic migratory erythema (NME) is pathognomonic of glucagonoma syndrome associated with pancreatic neoplasm. Pseudoglucagonoma syndrome, which is extremely rare, refers to NME without a glucagon-secreting tumor.
Nikita, Siba Prasad Dalai, Samir Sahu, Aswini Kumar Sahoo   +3 more
doaj  

Why Is the Duration of Erythema Migrans at Diagnosis Longer in Patients with Lyme Neuroborreliosis Than in Those without Neurologic Involvement? [PDF]

Pathogens
Ogrinc K, Bogovič P, Maraspin V, Lotrič-Furlan S, Rojko T, Kastrin A, Strle K, Wormser GP, Strle F.   +8 more
europepmc   +1 more source

Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months. [PDF]

Clin Infect Dis, 2020
Wormser GP, McKenna D, Karmen CL, Shaffer KD, Silverman JH, Nowakowski J, Scavarda C, Shapiro ED, Visintainer P.   +8 more
europepmc   +1 more source

Erythema Migrans: Course and Outcome in Patients Treated With Rituximab. [PDF]

Open Forum Infect Dis, 2019
Maraspin V, Bogovič P, Rojko T, Ružić-Sabljić E, Strle F.   +4 more
europepmc   +1 more source

Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection. [PDF]

Brain Behav Immun Health, 2020
Fallon BA, Strobino B, Reim S, Stoner J, Cunningham MW.   +4 more
europepmc   +1 more source

Erythema Migrans-like Rash Mimicking Lyme Disease. [PDF]

Intern Med, 2019
Fukushima K, Yanagisawa N, Kawabata H, Yajima K.   +3 more
europepmc   +1 more source